Journal Article Summary
The article focuses on chronic kidney disease-associated pruritus (CKD-aP), a common and distressing symptom experienced by patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). This condition significantly impacts patients' quality of life, including their sleep and overall well-being. Understanding the causes and potential treatments for CKD-aP is crucial, as the underlying mechanisms are complex and not fully understood, which makes effective management challenging.
The authors reviewed existing literature to summarize the prevalence, causes, and treatments of CKD-aP. They found that the prevalence of this condition varies widely, with studies reporting rates between 18% and nearly 98% among patients undergoing hemodialysis. The review highlighted several potential contributors to CKD-aP, including the accumulation of uremic toxins, inflammation, and dysregulation of the opioid system. While difelikefalin, a new medication approved for CKD-aP, shows promise, there remains a lack of highly effective treatments, and many patients do not receive adequate care for their symptoms.
The article also discusses limitations in the current understanding and treatment of CKD-aP, emphasizing that many studies are small or not rigorously controlled. Patients should be aware that CKD-aP is often underreported and may not be adequately addressed by healthcare providers. It is important for individuals experiencing itchiness or discomfort to discuss these symptoms with their healthcare professionals, as they may indicate underlying issues that need attention or could benefit from specific treatments.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Azimi Seyyede Zeinab, Lerner Ethan A.. Chronic kidney disease and itch. Itch (Philadelphia, Pa.) 2024. DOI: 10.1097/itx.0000000000000076. PMID: 41450907. PMCID: PMC12734897.
Featured Pill Pals Product
Loratadine 10 mg --- 300 Count Bottle --- Generic For Claritin --- Major / Rugby --- Over The Counter
Loratadine 10 mg — 300 Count Bottle — Generic For Claritin — Major / Rugby — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
